Table 1. Recommended grouping of patients for paediatric DRLs. In the transition period, age can be used as an additional parameter for patient grouping and for the purpose of comparison of proposed ...

Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 ...